Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1Bacillus Subtilis[1] Bacillus subtilis (Bacillus subtilis)---[3] 6, 28, 96 💬
2Bacillus subtilis Capsules[1] Bacillus subtilis (Bacillus subtilis)---[1] 96 💬
3Live Combined Bacillus Subtilis and Enterococcus Faecium Enteric-coated Capsules combined with Bortezomib+Dexamethasone/Bortezomib+Dexamethasone+Daratumumab/single Daratumumab[5] Bacillus subtilis (Bacillus subtilis),
Bortezomib,
Daratumumab,
Dexamethasone,
Enterococcus faecium
[5] Dexamethasone ,
Dexamethasone sodium phosphate ,
Bortezomib ,
Dexamethasone phosphate ,
Daratumumab 💬
[3] CD38,
NR3C1,
PSMB5 💬
[15] Alzheimer disease, Amyotrophic lateral sclerosis, Calcium signaling pathway, Hematopoietic cell lineage, Huntington disease, Neuroactive ligand-receptor interaction, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Salivary secretion, Spinocerebellar ataxia 💬[1] 28 💬